{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antiviral",
      "Cornea",
      "Dengue virus",
      "ISG15",
      "Innate immune response",
      "Zika virus"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30905842",
  "DateCompleted": {
    "Year": "2020",
    "Month": "09",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "09",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "03",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jtos.2019.03.006",
      "S1542-0124(19)30018-7"
    ],
    "Journal": {
      "ISSN": "1937-5913",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "3",
        "PubDate": {
          "Year": "2019",
          "Month": "Jul"
        }
      },
      "Title": "The ocular surface",
      "ISOAbbreviation": "Ocul Surf"
    },
    "ArticleTitle": "Interferon-stimulated gene 15 (ISG15) restricts Zika virus replication in primary human corneal epithelial cells.",
    "Pagination": {
      "StartPage": "551",
      "EndPage": "559",
      "MedlinePgn": "551-559"
    },
    "Abstract": {
      "AbstractText": [
        "Zika virus (ZIKV) has emerged as an important human pathogen causing ocular complications. There have been reports of the shedding of ZIKV in human as well as animal tears. In this study, we investigated the infectivity of ZIKV in corneal epithelial cells and their antiviral immune response.",
        "Primary human corneal epithelial cells (Pr. HCECs) and an immortalized cell line (HUCL) were infected with two different strains of ZIKV (PRVABC59 & BeH823339) or dengue virus (DENV, serotypes 1-4). Viral infectivity was assessed by immunostaining of viral antigen and plaque assay. qRT-PCR and immunoblot analyses were used to assess the expression of innate inflammatory and antiviral genes. Supplementation of recombinant ISG15 (rISG15) and gene silencing approaches were used to elucidate the role of ISG15 in corneal antiviral defense.",
        "Pr. HCECs, but not the HUCL cells, were permissive to both ZIKV strains and specifically to DENV3 infection. ZIKV induced the expression of viral recognition receptors (TLR3, RIG-I, &MDA5), and genes involved in inflammatory (CXCL10 & CCL5) and antiviral (IFNs, MX1, OAS2, ISG15) responses in Pr. HCECs. Furthermore, ZIKV infection caused Pr. HCECs cell death, as evidenced by TUNEL staining. Silencing of ISG15 increased ZIKV infectivity while supplementation with rISG15 reduced ZIKV infection by direct inactivation of ZIKV and inhibiting its entry.",
        "Our study demonstrates for the first time, that ZIKV can readily infect and replicate in Pr. HCECs. Therefore, ZIKV may persist in the cornea and pose the potential risk of transmission via corneal transplantation."
      ],
      "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, MI, USA."
          }
        ],
        "LastName": "Singh",
        "ForeName": "Pawan Kumar",
        "Initials": "PK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, MI, USA."
          }
        ],
        "LastName": "Singh",
        "ForeName": "Sneha",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemistry, Microbiology and Immunology, Wayne State University, Detroit, MI, USA."
          }
        ],
        "LastName": "Farr",
        "ForeName": "Dustin",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, MI, USA; Department of Biochemistry, Microbiology and Immunology, Wayne State University, Detroit, MI, USA. Electronic address: akuma@med.wayne.edu."
          }
        ],
        "LastName": "Kumar",
        "ForeName": "Ashok",
        "Initials": "A"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 EY004068",
        "Acronym": "EY",
        "Agency": "NEI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 EY026964",
        "Acronym": "EY",
        "Agency": "NEI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 EY027381",
        "Acronym": "EY",
        "Agency": "NEI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 AI135583",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Ocul Surf",
    "NlmUniqueID": "101156063",
    "ISSNLinking": "1542-0124"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cytokines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ubiquitins"
    },
    {
      "RegistryNumber": "60267-61-0",
      "NameOfSubstance": "ISG15 protein, human"
    },
    {
      "RegistryNumber": "63231-63-0",
      "NameOfSubstance": "RNA"
    },
    {
      "RegistryNumber": "9008-11-1",
      "NameOfSubstance": "Interferons"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Cytokines"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Epithelium, Corneal"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Eye Infections, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunoblotting"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Interferons"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "RNA"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Ubiquitins"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Replication"
    },
    {
      "QualifierName": [
        "growth & development"
      ],
      "DescriptorName": "Zika Virus"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Zika Virus Infection"
    }
  ],
  "CoiStatement": "Conflict of interest. The authors declare no financial conflict of interest."
}